PACT Advocacy Academy: Towards better access to care and treatment globally | Global Policy and Access Summit 2021
In this session from the Global Policy and Access Summit, Donna Coffin, Salome Mekhuzla, Carlos Safadi Marquez, John Gershman and Mathieu Jackson present an overview of the WFH’s Path to Access to Care and Treatment (PACT) Program and launch the new PACT Advocacy Academy – an 8-month training course for NMO leaders and advocates developed […]
Models of care delivery today and in the post-pandemic world | Global Policy and Access Summit 2021
In this session from the Global Policy and Access Summit, Dan Hart, Margareth Ozelo, Hatoon Mohammed and Daniel Anibal Garcia discuss how the pandemic has brought many challenges to the existing models of organization and delivery of care. This session highlights the opportunities that also arise in the post-pandemic era. Presenters will share different case […]
WBDR 2021 Data Report
The World Bleeding Disorders Registry (WBDR) 2021 Data Report provides aggregate data on more than 9,000 people with hemophilia around the globe who are enrolled in the WBDR. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific […]
Effective strategies to improve access to treatment and care | Global Policy and Access Summit 2021
In this session from the Global Policy and Access Summit, Dawn Rotellini, Bradley Rayner, Declan Noone and Durhane Wong-Rieger, will address the importance of data analysis to inform policy decisions, building alliances with patient groups and other effective strategies to improve access to treatment and care for people with bleeding disorders. Emphasis will be made […]
Economics of care and access to therapies | Global Policy and Access Summit 2021
In this session from the Global Policy and Access Summit, Dawn Rotellini, Mark Skinner, Jamie O’Hara and David Page will present an overview of the current state of access to therapies for people with bleeding disorders. Speakers will also highlight the importance of patient-relevant data on treatment choices and health policy decision-making. Session will include […]
Current landscape of access to treatment & care globally | Global Policy and Access Summit 2021
How is the pandemic impacting global healthcare systems around the world? What will the “new normal” be? In this opening session from the Global Policy and Access Summit, Cesar Garrido (WFH President) and Glenn Pierce, MD (WFH VP Medical) will address the effects of the pandemic on WFH’s vision of Treatment for All, as well […]
Collaborating to increase access: Perspectives from different stakeholders | Global Policy and Access Summit 2021
In this session from the Global Policy and Access Summit, Glenn Pierce, MD (WFH VP Medical), will moderate a panel discussion with Megan Adediran, Emna Gouider & Latifa Belakhel, bringing together perspectives from a patient organization leader, a healthcare provider and a national government representative. This discussion will highlight potential areas of collaboration between stakeholders […]
Recommendations and key take aways | Global Policy and Access Summit 2021
In this final session from the Global Policy and Access Summit, Salome Mekhuzla, David Page, Mukesh Garodia and Antonio Gomez Cavallini discuss how the global bleeding disorders community is sustaining and advancing care today and in the post-pandemic world. They will also cover the strategies that have proven successful, and what contributions various stakeholders bring […]
Monitoring Patient Safety in Clinical Trials
Ensuring patient safety is of paramount importance during the clinical trial process. There are many levels of study approval and monitoring to protect the safety of participants in clinical trials, and a system in place for collecting and reporting safety outcomes during a study. The WFH does not engage in the practice of medicine and […]
Patient and Healthcare Provider Roles in Clinical Trials
Participants in clinical trials and health care providers have different roles throughout the clinical trial process. It is important that both are educated and fully understand their roles. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific […]
Questions to Ask Before Participating in a Clinical Trial
For people considering participation in a clinical trial, it is extremely important to learn as much as possible about the clinical trial, the care expected, the cost, and the team that will be conducting the trial. It is expected that you will have questions, and essential that your questions are answered. It may be helpful […]
How New Therapies Get Tested in Clinical Trials
For a drug to become a treatment that doctors can prescribe, it must first be tested in a series of clinical trial phases, and then assessed and approved by a regulatory agency. Each clinical trial phase has a purpose, and the phases progress in order from Phase 1 to Phase 4. The WFH does not […]